Showing results (91-100 of 177) with videos related to

Sort By:
Pageof 18
Future Oncology (London, England)|April 14, 2026
Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01Arun A Azad, Neeraj Agarwal, Andrew J Armstrong, et al.
Translational Andrology and Urology|January 12, 2023
Management of patients with advanced prostate cancer in Japan: 'real-world' consideration of the results from the Advanced Prostate Cancer Consensus ConferenceKazutoshi Fujita, Hiroyoshi Suzuki, Nobuyuki Hinata, et al.
Urologia Internationalis|August 5, 2021
Incidental Bladder Cancer Found on Cystoscopy during Prostate Biopsy: Prevalence, Pathological Findings, and Oncological OutcomeYoichiro Tohi, Yasuyuki Miyauchi, Mari Yamasaki, et al.
The Prostate|February 10, 2023
Detection of intraductal carcinoma in prostate cancer patients with small tumor volumeNobushige Takeshita, Shinichi Sakamoto, Yasutaka Yamada, et al.
Photodiagnosis and Photodynamic Therapy|July 14, 2023
Oral 5-aminolevulinic acid administration before transurethral resection of bladder tumor induces perioperative nausea and vomitingRikiya Taoka, Keisuke Yamada, Yoshiharu Sawanobori, et al.
Japanese Journal of Clinical Oncology|June 10, 2015
Impact of renal function of patients with advanced urothelial cancer on eligibility for first-line chemotherapy and treatment outcomesDaishi Ichioka, Jun Miyazaki, Takamitsu Inoue, et al.
Research and Reports in Urology|September 15, 2021
Positive Culture Prior to Transperineal Prostate Biopsy Was Not Associated with Post-Biopsy Febrile Urinary Tract Infection DevelopmentYoichiro Tohi, Kengo Fujiwara, Satoshi Harada, et al.
Urology|December 7, 2020
The Impact of Histopathological Features of Prostate Cancerous Lesions on Multiparametric Magnetic Resonance Imaging Findings using PI-RADS Version 2Hirohito Naito, Takuma Kato, Ryou Ishikawa, et al.
Molecular and Clinical Oncology|February 19, 2021
The predictive factor for pathological downgrading after prostatectomy in patients with biopsy Gleason score 4+3 or 4+4 prostate cancerYoichiro Tohi, Iori Matsuda, Kengo Fujiwara, et al.
Cancers|March 28, 2025
Nerve-Sparing Robotic-Assisted Radical Prostatectomy Based on the Absence of Prostate Imaging-Reporting and Data System ≥3 or Biopsy Gleason Pattern ≥4 in the Peripheral ZoneYoichiro Tohi, Hiroyuki Tsunemori, Kengo Fujiwara, et al.
Pageof 18